154 related articles for article (PubMed ID: 38073338)
1. Causes of death among people with myelomeningocele: A multi-institutional 47-year retrospective study.
Szymanski KM; Adams CM; Alkawaldeh MY; Austin PF; Bowman RM; Castillo H; Castillo J; Chu DI; Estrada CR; Fascelli M; Frimberger DC; Gargollo PC; Hamdan DG; Hecht SL; Hopson B; Husmann DA; Jacobs MA; MacNeily AE; McLeod DJ; Metcalfe PD; Meyer T; Misseri R; O'Neil J; Rensing AJ; Routh JC; Rove KO; Sawin KJ; Schlomer BJ; Shamblin I; Sherlock RL; Slobodov G; Stout J; Tanaka ST; Weiss DA; Wiener JS; Wood HM; Yerkes EB; Blount J
J Pediatr Rehabil Med; 2023; 16(4):605-619. PubMed ID: 38073338
[TBL] [Abstract][Full Text] [Related]
2. Reviewing the prognostic factors in myelomeningocele.
Protzenko T; Bellas A; Pousa MS; Protzenko M; Fontes JM; de Lima Silveira AM; Sá CA; Pereira JP; Salomão RM; Salomão JFM; Dos Santos Gomes SC
Neurosurg Focus; 2019 Oct; 47(4):E2. PubMed ID: 31574474
[TBL] [Abstract][Full Text] [Related]
3. Shunt revision rates in myelomeningocele patients in the first year of life: a retrospective study of 52 patients.
Alatas I; Canaz G; Kayran NA; Kara N; Canaz H
Childs Nerv Syst; 2018 May; 34(5):919-923. PubMed ID: 29159427
[TBL] [Abstract][Full Text] [Related]
4. First 60 fetal in-utero myelomeningocele repairs at Saint Louis Fetal Care Institute in the post-MOMS trial era: hydrocephalus treatment outcomes (endoscopic third ventriculostomy versus ventriculo-peritoneal shunt).
Elbabaa SK; Gildehaus AM; Pierson MJ; Albers JA; Vlastos EJ
Childs Nerv Syst; 2017 Jul; 33(7):1157-1168. PubMed ID: 28470384
[TBL] [Abstract][Full Text] [Related]
5. Myelomeningocele-associated hydrocephalus: nationwide analysis and systematic review.
McCarthy DJ; Sheinberg DL; Luther E; McCrea HJ
Neurosurg Focus; 2019 Oct; 47(4):E5. PubMed ID: 31574479
[TBL] [Abstract][Full Text] [Related]
6. Rate of shunt revision as a function of age in patients with shunted hydrocephalus due to myelomeningocele.
Dupepe EB; Hopson B; Johnston JM; Rozzelle CJ; Jerry Oakes W; Blount JP; Rocque BG
Neurosurg Focus; 2016 Nov; 41(5):E6. PubMed ID: 27798984
[TBL] [Abstract][Full Text] [Related]
7. The Effectiveness of Antibiotic-Coated Ventriculoperitoneal Shunts for Prevention of Shunt Infections in Patients with Myelomeningocele.
Ertuğrul B; Kaplan M; Batu Hergünsel Ö; Akgün B; Öztürk S; Serhat Erol F
Pediatr Neurosurg; 2021; 56(4):357-360. PubMed ID: 34034264
[TBL] [Abstract][Full Text] [Related]
8. Contemporary management and outcome of myelomeningocele: the Rotterdam experience.
Spoor JKH; Gadjradj PS; Eggink AJ; DeKoninck PLJ; Lutters B; Scheepe JR; van Meeteren J; de Laat PCJ; van Veelen ML; de Jong THR
Neurosurg Focus; 2019 Oct; 47(4):E3. PubMed ID: 31574477
[TBL] [Abstract][Full Text] [Related]
9. Pediatric hydrocephalus: 40-year outcomes in 128 hydrocephalic patients treated with shunts during childhood. Assessment of surgical outcome, work participation, and health-related quality of life.
Paulsen AH; Lundar T; Lindegaard KF
J Neurosurg Pediatr; 2015 Dec; 16(6):633-41. PubMed ID: 26359766
[TBL] [Abstract][Full Text] [Related]
10. Predictors of the need for cerebrospinal fluid diversion in patients with myelomeningocele.
Phillips BC; Gelsomino M; Pownall AL; Ocal E; Spencer HJ; O'Brien MS; Albert GW
J Neurosurg Pediatr; 2014 Aug; 14(2):167-72. PubMed ID: 24877604
[TBL] [Abstract][Full Text] [Related]
11. Experience in shunt management on revision free survival in infants with myelomeningocele.
Al-Hakim S; Schaumann A; Schneider J; Schulz M; Thomale UW
Childs Nerv Syst; 2018 Jul; 34(7):1375-1382. PubMed ID: 29582171
[TBL] [Abstract][Full Text] [Related]
12. The Association between the Timing of Shunt Placement and Shunt Infection in Hydrocephalus Associated with Myelomeningocele.
Gurbuz MS; Yuksel MO
Turk Neurosurg; 2020; 30(1):94-98. PubMed ID: 31452179
[TBL] [Abstract][Full Text] [Related]
13. Shunt infection and malfunction in patients with myelomeningocele.
White MD; McDowell MM; Agarwal N; Greene S
J Neurosurg Pediatr; 2021 Feb; 27(5):518-524. PubMed ID: 33636695
[TBL] [Abstract][Full Text] [Related]
14. Timing of ventriculoperitoneal shunt insertion following spina bifida closure in Kenya.
Margaron FC; Poenaru D; Bransford R; Albright AL
Childs Nerv Syst; 2010 Nov; 26(11):1523-8. PubMed ID: 20422197
[TBL] [Abstract][Full Text] [Related]
15. Age-based risk of end-stage kidney disease in patients with myelomeningocele.
Adams CM; Misseri R; Roth JD; Whittam BM; Guckien ZE; King SJ; Kaefer M; Rink RC; Szymanski KM
J Pediatr Urol; 2023 Apr; 19(2):195.e1-195.e7. PubMed ID: 36628830
[TBL] [Abstract][Full Text] [Related]
16. The Use of External Ventricular Drainage to Reduce the Frequency of Wound Complications in Myelomeningocele Closure.
McDowell MM; Lee PS; Foster KA; Greene S
Pediatr Neurosurg; 2018; 53(2):100-107. PubMed ID: 29316543
[TBL] [Abstract][Full Text] [Related]
17. What is the Role of Scoliosis Surgery in Adolescents and Adults with Myelomeningocele? A Systematic Review.
Bradko V; Castillo H; Fremion E; Conklin M; Dahl B; Castillo J
Clin Orthop Relat Res; 2022 Apr; 480(4):773-787. PubMed ID: 34939968
[TBL] [Abstract][Full Text] [Related]
18. Contemporaneous shunting with repair of myelomeningocele.
Parent AD; McMillan T
Pediatr Neurosurg; 1995; 22(3):132-5; discussion 136. PubMed ID: 7786805
[TBL] [Abstract][Full Text] [Related]
19. About the rate of shunt complications in patients with hydrocephalus and myelomeningocele.
Rolle U; Gräfe G
Eur J Pediatr Surg; 1999 Dec; 9 Suppl 1():51-2. PubMed ID: 10661803
[No Abstract] [Full Text] [Related]
20. Swedish cohort study found that half of the girls with shunted hydrocephalus had precocious or early puberty.
Dahl M; Proos LA; Arnell K; Gustafsson J
Acta Paediatr; 2024 Apr; 113(4):827-832. PubMed ID: 38233740
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
